Senior Scientist
CurrentIn vivo selection strain development team in support of a U.S. Defense Threat Reduction Agency (DTRA) grant research program • Provide support for selection of a genetically engineered bacterial strain capable of screening large libraries of candidate reporter enzymes. This complementation assay will be used to develop an implantable electrode to monitor human biomarkers. • Perform recombineering techniques including P1 phage transductions, competent cell preparations and bacterial electroporation/transformationAssay development team member for a multi-analyte respiratory diagnostic on the MAP (Mobile Analysis Platform)• Performed assay design, optimization and validation on a diagnostic platform incorporating microfluidics and multiplex RT/PCR for detection of viral RNA via oligonucleotide probe hybridization on a microarray. The diagnostic platform was developed for the Defense Advanced Research Projects Agency (DARPA).• Conducted on-site personnel training for IRB reviewed clinical studies at the Naval Health Research Center and John Hopkins University School of Medicine.Supported Verification & Validation project teams for bacterial, fungal and viral assays on the CE Marked IRIDICA in vitro diagnostic platform. • Direct pathogen identification on the IRIDICA platform using human clinical and contrived specimens. Performed sample preparation, nucleic acid amplification, post PCR-purification and analysis by ESI mass spectrometry. • Assisted Quality Assurance department with documentation review for CE Mark compliance. Trained in over 150 courses in Abbott Quality System for product design, development, verification and validation. Certified CAPA Respondent. Responsible for maintaining all USDA and CDC permits for the transport and use of viral, bacterial and fungal pathogens.